Skip to main content

Cancer Matters

Author Archives

Prostate Cancer Part 14 (Finale) – Current Advances In Techniques And Technologies In Prostate Cancer Management In 2026

The clinical landscape of prostate cancer management in 2026 is marked by a sweeping integration of diagnostic precision and multi-modal, patient-tailored interventions. The era of uniform, invasive...

Prostate Cancer Part 13 – Beyond The Standard Hormonal Therapy For Metastatic Prostate Cancer 

Beyond the standard “triplet therapy” and established hormone treatments, the research landscape for 2026 is rapidly expanding into precision medicine and “paradoxical”...

Prostate Cancer Part 12 – The Management Of Metastatic (Advanced) Prostate Cancer In 2026   

The management of metastatic prostate cancer has undergone a radical shift from sequential hormone therapy to “upfront intensification.” As of 2026, the standard of care is defined by...

Prostate Cancer Part 11 – Landmark Clinical Trials In Prostate Cancer Management 

Prostate cancer is a clinically complex malignancy that can range from indolent, slow-growing localised tumours to aggressive, metastatic disease. Because these presentations are highly heterogeneous...

Prostate Cancer Part 10 – Understanding The Various Eras And Progress In Prostate Cancer Management 

Understanding the evolution of prostate cancer treatment from the historic hormonal ablation to modern precision oncology is essential. It prevents repeating past mistakes, reveals how...

Prostate Cancer Part 9 – Advanced (Metastatic) Prostate Cancer: Terminologies Used And Understanding The Basis Of Clinical Trials In Advanced Prostate Cancer

To be considered a specialist in prostate cancer, the treating specialist must possess comprehensive knowledge that extends beyond simply knowing current treatment modalities. They must have a deep...

Prostate Cancer Part 8 – Management of Locally Advanced Prostate Cancer In 2026 

Locally advanced prostate cancer (LAPC) refers to tumors that have grown outside the prostate capsule or spread to immediately adjacent tissues (like the seminal vesicles or pelvic...

Prostate Cancer Part 7 – A Critical Analysis Of Landmark Clinical Trials In Localised Prostate Cancer 

An Evidence Based Approach In Prostate Cancer Treatment  As medical professionals, our patient management should be evidence-based, not on hearsay or public social media...

Prostate Cancer Part 6 – Beyond Radical Prostatectomy And Radiotherapy: Focal Therapy In Localised Prostate Cancer 

Beyond Radical Prostatectomy (RP) and Radiotherapy (RT), several focal therapy modalities have emerged. As of 2026, Focal Therapy in localised prostate cancer is...

Prostate Cancer Part 5 – Key Knowledge Areas For Radiotherapy In 2026 

Radiotherapy is a standard, highly effective treatment for prostate cancer, often offering cure rates comparable to surgery. It is used as a primary treatment for localised disease, combined with...